Actelion Vows To Appeal Jury Verdict In Asahi Fight

Actelion Ltd. vowed Wednesday to appeal a California jury verdict ordering it to pay Asahi Kasei Pharma Corp. $547 million in damages for interfering with an Asahi drug development licensing agreement...

Already a subscriber? Click here to view full article